278 algorithm-development-"Multiple"-"Simons-Foundation" "Prof" positions at University of London
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to providing an outstanding level of customer service. Exceptional attention to detail and excellent time management skills. Skilled in handling a busy workload, prioritising multiple deadlines, and
-
to cancer treatment delays. The successful candidate will join 50 researchers on 10 National Cancer Audits https://www.natcan.org.uk/ . The postholder will report to Prof Ajay Aggarwal (co-PI, TACTIC and
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving
-
databases. Based in the Centre for Primary Care at Whitechapel, you will join a creative, collaborative, multi-disciplinary research team, led by Dr Anna De Simoni and Prof Chris Griffiths from the Centre
-
diabetes and prediabetes by analysing voice patterns, providing a non-invasive and innovative method for early diagnosis. Specifically, this project will develop novel deep learning algorithms, and audio and
-
clients. Ability to manage multiple internal and external stakeholders and to operate effectively with senior leaders. Experience of key account management and developing client relationships. Extensive
-
to develop a broad range of skills and experiences as a platform for career development, within a vibrant global health research group led by Professor Andrew Prendergast. The post is based in the Centre
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving